AU2003222068A8 - Improved methods for achieving expression from alphavirus vectors - Google Patents

Improved methods for achieving expression from alphavirus vectors

Info

Publication number
AU2003222068A8
AU2003222068A8 AU2003222068A AU2003222068A AU2003222068A8 AU 2003222068 A8 AU2003222068 A8 AU 2003222068A8 AU 2003222068 A AU2003222068 A AU 2003222068A AU 2003222068 A AU2003222068 A AU 2003222068A AU 2003222068 A8 AU2003222068 A8 AU 2003222068A8
Authority
AU
Australia
Prior art keywords
improved methods
alphavirus vectors
achieving expression
achieving
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003222068A
Other versions
AU2003222068A1 (en
Inventor
Jiagang Wang
William B Klimstra
Laura J White
Robert E Johnston
Kate D Ryman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
University of North Carolina System
Original Assignee
University of North Carolina at Chapel Hill
University of North Carolina System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill, University of North Carolina System filed Critical University of North Carolina at Chapel Hill
Publication of AU2003222068A8 publication Critical patent/AU2003222068A8/en
Publication of AU2003222068A1 publication Critical patent/AU2003222068A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36161—Methods of inactivation or attenuation
AU2003222068A 2002-03-25 2003-03-25 Improved methods for achieving expression from alphavirus vectors Abandoned AU2003222068A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36789302P 2002-03-25 2002-03-25
US36777602P 2002-03-25 2002-03-25
US60/367,893 2002-03-25
US60/367,776 2002-03-25
PCT/US2003/009121 WO2003083065A2 (en) 2002-03-25 2003-03-25 Improved methods for achieving expression from alphavirus vectors

Publications (2)

Publication Number Publication Date
AU2003222068A8 true AU2003222068A8 (en) 2003-10-13
AU2003222068A1 AU2003222068A1 (en) 2003-10-13

Family

ID=28678198

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003222068A Abandoned AU2003222068A1 (en) 2002-03-25 2003-03-25 Improved methods for achieving expression from alphavirus vectors

Country Status (2)

Country Link
AU (1) AU2003222068A1 (en)
WO (1) WO2003083065A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60233061D1 (en) 2001-09-06 2009-09-03 Alphavax Inc ALPHAVIRUS REPLICON VECTOR SYSTEMS
DK1651666T3 (en) 2003-07-11 2009-08-31 Alphavax Inc Alphavirus-based cytomegalovirus vaccines
AU2005327198B2 (en) 2004-07-09 2011-03-31 University Of North Carolina At Chapel Hill Viral adjuvants
AU2006302794B2 (en) 2005-02-15 2011-08-04 Children's Hospital, Inc. New live virus vaccines
ES2304880B1 (en) * 2007-04-03 2009-10-27 Proyecto De Biomedicina Cima, S.L. USE OF A MUTED VIRAL VECTOR FOR THE IN VITRO GENERATION OF STABLE CELLULAR LINES.
AU2008266807B2 (en) 2007-06-21 2012-08-16 Alphavax, Inc. Promoterless cassettes for expression of alphavirus structural proteins
GB201310432D0 (en) * 2013-06-12 2013-07-24 Univ St Andrews Virus Production
WO2015118146A1 (en) 2014-02-10 2015-08-13 Univercells Nv System, apparatus and method for biomolecules production
US20210275615A1 (en) * 2018-09-14 2021-09-09 Laura Evgin Materials and methods for treatment with oncolytic viruses and modified car t cells
CA3119752A1 (en) * 2018-11-07 2020-05-14 Gritstone Oncology, Inc. Alphavirus neoantigen vectors and interferon inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015686A (en) * 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems

Also Published As

Publication number Publication date
AU2003222068A1 (en) 2003-10-13
WO2003083065A3 (en) 2004-07-29
WO2003083065A2 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
GB0325379D0 (en) Vectors
EP1441537A4 (en) Method for calculating motion vector
AU2003221733A8 (en) Improved raav vectors
AU2003206898A8 (en) Method for rate matching
PL377171A1 (en) Method for producing oligomers derived from butenes
GB0215113D0 (en) Authentication method
GB0230201D0 (en) Retargeting
EP1581234A4 (en) Methods for treating migraine
GB2395539B (en) Umbilical
AU2003222068A8 (en) Improved methods for achieving expression from alphavirus vectors
PL378060A1 (en) Novel vector
GB0208928D0 (en) Methods
GB0320207D0 (en) Methods
GB0221711D0 (en) Methods
EP1616957A4 (en) Vector
GB0223215D0 (en) Processs
AU2003253447A8 (en) Expression vectors
GB0219723D0 (en) Methods
GB0204967D0 (en) Methods
PL374000A1 (en) Improved process for hydroxyazapirones
GB0209023D0 (en) Expression vector
GB0202213D0 (en) Methods
GB0222276D0 (en) Methods
AU2002367923A8 (en) Method for preparing 2-alkoxyphenoxyethanamines from 2-alkoxyphenoxyethylacetamides
GB0200526D0 (en) Methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase